ORGANIC
LETTERS
1999
Vol. 1, No. 7
973-976
Stereocontrolled Total Synthesis of
(±)-Catharanthine via Radical-Mediated
Indole Formation
Matthew T. Reding† and Tohru Fukuyama*
Graduate School of Pharmaceutical Sciences, The UniVersity of Tokyo,
CREST, The Japan Science and Technology Corporation (JST),
7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan
Received June 21, 1999
ABSTRACT
A stereocontrolled total synthesis of (±)-catharanthine, 1, has been completed. The key step involves the radical-mediated cyclization of a
highly functionalized intermediate to furnish the corresponding indole. The cyclization utilizes a simple phosphorus-based radical-reducing
agent. This synthesis provides a potential route for the production of analogues of catharanthine and is more convergent and experimentally
less complex than previous syntheses of 1.
Catharanthine, 1, is an important member of the Iboga class
of alkaloids.1 It is a chemical and presumed biological
precursor of the antitumor alkaloids vinblastine and vin-
cristine, two venerable yet effective anticancer agents used
in the treatment of a number of human cancers.2 The dense,
pentacyclic skeleton of 1 contains a tryptamine fragment
substituted at the 2-position by a quaternary sp3 carbon, and
thereby represents an attractive challenge to our recently
disclosed methodology for the synthesis of 2,3-disubstituted
indoles.3 The successful completion of this synthesis dem-
onstrates the utility of this radical-based methodology for
the construction of complex indole-containing natural prod-
ucts.
(()-Catharanthine has been the target of numerous suc-
cessful total and formal total syntheses.4-6 However, all of
the previously reported routes to 1 have made use of
preexisting indolyl frameworks,7 and as such offer little hope
for the facile construction of analogues of 1 substituted on
the aromatic carbocyle. Controlled access to such compounds
is essential for the rational examination of structure and
activity relationships of the derived drugs. Furthermore,
recent syntheses of 1 have relied on nonstereocontrolled
(4) Total syntheses: (a) Bu¨chi, G.; Kulsa, P.; Ogasawara, K.; Rosati, R.
L. J. Am. Chem. Soc. 1970, 92, 999. (b) Kutney, J. P.; Bylsma, F. HelV.
Chim. Acta 1975, 58, 1672. (c) Andriamialisoa, R. Z.; Langlois, N.; Langlois,
Y. Heterocycles 1980, 14, 1457. (d) Marazano, C.; LeGoff, M.; Fourrey,
J.; Das, B. C. J. Chem. Soc., Chem. Commun. 1981, 389. (e) Raucher, S.;
Bray, B. L. J. Org. Chem. 1985, 50, 3236. (f) Kuehne, M. E.; Bornmann,
W. G.; Earley, W. G.; Marko, I. J. Org. Chem. 1986, 51, 2913. (g) Raucher,
S.; Bray, B. L.; Lawrence, R. F. J. Am. Chem. Soc. 1987, 109, 442. (h)
Sza´ntay, C.; Bo¨lcskei, H.; Ga´cs-Baitz, E. Tetrahedron 1990, 46, 1711.
(5) Formal syntheses: (a) Trost, B. M.; Godleski, S. A.; Belletire, J. L.
J. Org. Chem. 1979, 44, 2052. (b) Imanishi, T.; Shin, H.; Yagi, N.; Hanaoka,
M. Tetrahedron Lett. 1980, 21, 3285. (c) Imanishi, T.; Yagi, N.; Shin, H.;
Hanaoka, M. Chem. Pharm. Bull. 1982, 30, 4052.
† Current Address: Department of Structural, Analytical & Medicinal
Chemistry, Pharmacia & Upjohn, Kalamazoo, MI 49001.
(1) (a) Gorman, M.; Neuss, N.; Svoboda, G. H.; Barnes, A. J.; Cone, N.
J. J. Am. Pharm. Assoc. (Sci. Ed.) 1959, 48, 256. (b) Svoboda, G. H.; Neuss,
N.; Gorman, M. J. Am. Pharm. Assoc. (Sci. Ed.) 1959, 48, 659. (c) Neuss,
N.; Gorman, M. Tetrahedron Lett. 1961, 206. (d) Gorman, M.; Neuss, N.;
Cone, N. J. J. Am. Chem. Soc. 1965, 87, 93. (e) Bu¨chi, G.; Coffen, D. L.;
Kocsis, K.; Sonnet, P. E.; Ziegler, F. E. J. Am. Chem. Soc. 1966, 88, 3099.
(2) The Alkaloids. Antitumor Bisindole Alkaloids from Catharanthus
roseus (L.); Brossi, A., Suffness, M., Eds.; Academic Press: San Diego,
1990; Vol. 37.
(6) Only one account of a nonracemic synthesis of 1, via resolution, has
been published (see ref 4h).
(7) All of the syntheses listed in refs 4 and 5 utilize 2-indoleacetic acid
or tryptamine as their indole source, except ref 4d, which begins with
thioxindole.
(3) Tokuyama, H.; Yamashita, T.; Reding, M. T.; Kaburagi, Y.;
Fukuyama, T. J. Am. Chem. Soc. 1999, 121, 3791.
10.1021/ol990749i CCC: $18.00 © 1999 American Chemical Society
Published on Web 09/08/1999